The Rigorous Science of Vaccine Safety

COVID-19 vaccines undergo one of the most intensive testing processes in modern medicine to ensure they meet global safety and efficacy standards. Before reaching the public, a vaccine must pass through multiple clinical phases: starting with small-scale Phase 1 trials to confirm basic safety and dosage, moving to Phase 2 to test immune response in diverse groups, and culminating in Phase 3 trials involving tens of thousands of volunteers. This structured approach, combined with continuous real-world monitoring (Pharmacovigilance), ensures that only vaccines with a proven benefit-to-risk ratio are authorized for use at institutions like Royal Care Hospital.